Translational Development Acquisition Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $237.9M
- Price
- $10.85
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.10%
- Volume
- 14.1K
About
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Quick stats
Shares outstanding21.9M
Computed float2.9M
Float / shares13.0%
Cash runway (months)-4.2
Key info
SectorFinancial Services
IndustryShell Companies
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001926599
AI Summary
AI-generated1/6
standardbullishoperations update
ProLogium and Translational Development Acquisition Corp. Announce $50 Million Committed Primary Capital Investment to Support Proposed Business Combination
TDAC and target ProLogium secured $50 million in committed capital from existing investors at a $3.8 billion pre-money valuation to support their proposed business combination.
Proceeds are earmarked for scaling next-generation lithium ceramic battery production and advancing the Dunkirk, France gigafactory construction.
The Dunkirk facility is supported by up to €1.375 billion in French government subsidies and aims for a maximum production capacity of 44.0 GWh.